Clinical Trial Update: Daily Nevirapine to Prevent Mother to Infant Transmission of HIV [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating daily nevirapine to prevent mother-to-child transmission of HIV has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Drugs mentioned

• NEVIRAPINE (nevirapine)

Snippet

Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) | Conditions: HIV Infections | Phase 3 | Status: COMPLETED